Melahat UZEL ŞENER, Ayperi ÖZTÜRK, Tuğba ÇİÇEK, Murat YILDIZ, Suna KAVURGACI, Figen Ergür ÖZTÜRK

Nötrofil/Lenfosit Oranının COVID-19’da Mortaliteyi Belirlemedeki Rolü

Amaç: Koronavirüs hastalığı (COVID-19)’nda tanısal hematolojik parametreler belirlendi. Yapılan çalışmalarda, COVID-19 hastalarında nötrofil/lenfosit oranı (NLR)’nın hastalığın şiddetini ve mortalitesini göstermede önemli bir belirteç olduğu belirtildi. Bu çalışmanın amacı, ucuz, kolay ölçülebilir ve tekrarlanabilir bir test olan NLR’nin kritik hastaların ayrımında kullanılabilirliğini tespit etmektir. Gereç ve Yöntemler: Çalışma, Sağlık Bilimleri Üniversitesi Ankara Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi’nde yapıldı. Çalışmaya, 01 Eylül 2020−01 Ekim 2020 tarihleri arasında hastanemize başvuran ve COVID-19 tanısı alarak servis yatışı gerektiren hastalar dahil edildi. Bulgular: Çalışmaya dahil edilen hastaların (n=360) yaş ortalaması 62,27±14,09 yıl, hastane takiplerinde vefat eden hastaların (n=42) yaş ortalaması 69,95±12,48 yıl, taburcu edilen hastaların (n=318) yaş ortalaması 61,25±13,99 yıl idi. Bu sonuçlara göre, vefat eden hastaların yaş ortalaması istatistiksel olarak anlamlı düzeyde yüksek bulundu (p

The role of Neutrophil/Lymphocyte Ratio in DeterminingCOVID-19 Mortality

Objective: A few diagnostic hematological parameters have been determined in COVID-19 disease. Neutrophil/lymphocyte ratio (NLR) was shown as a significant marker in indicating the severity of the disease and mortality in COVID-19 in several studies. We were aimed to determine the use of NLR to distinguish critically ill patients in this study. Material and Methods: A total of 360 patients who were diagnosed COVID-19 and required hospitalization through September 1, 2020–October 1, 2020, in the Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital were included in the study. Results: The mean age of all (n=360), dead (n=42), and alive (n=318) patients included in the study was 62.27±14.09, 69.95±12.48, and 61.25±13.99 years, respectively. The mean age of died patients was higher statistically (p5.688) group had statistically significantly higher C-reactive protein, D-dimer, ferritin, and troponin values, while the need for advanced oxygen therapy and the mortality rate were also higher in this group. Conclusion: NLR has important advantages of being easily calculated from the complete blood count, can be found in all hospitals and resulted shortly. These advantages can help clinicians increase their awareness in the management of their COVID-19 patients.

PDF

___

1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20.
2. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020;95:E131–4.
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.
4. Suastika NKW, Suega K. Diagnosticvalue of neutrophil to lymphocyte ratio for assessing the disease severity in Covid-19 patients. East J Med 2021;26:199–203.
5. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med 2020;18:206.
6. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020;9:687–90.
7. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 2002;169:4288–97.
8. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529–39.
9. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43.
10. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020;95:E131–4.
11. Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, et al. Changes in blood lymphocyte populations after multiple trauma: Association with posttraumatic complications. Crit Care Med 1999;27:733–40.
12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507–13.
13. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003;6:283–7.
14. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002;16:217–232.
15. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al Y. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2021;73:e4208–13.
16. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.
17. Sun S, Cai X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta 2020;507:174–80.
18. Vidal AC, Howard LE, de Hoedt A, Cooperberg MR, Kane CJ, Aronson WJ, et al. Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: Results from the SEARCH database. Cancer Causes Control 2018;29:581–8.
19. Kumarasamy C, Sabarimurugan S, Madurantakam RM, Lakhotiya K, Samiappan S, Baxi S, et al. Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14834.
20. Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 2017;10:12.
21. Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine (Baltimore) 2018;97:e11138.
22. McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treat Rev 2013;39:534–40.
23. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218–30.
24. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504.
25. Sun S, Cai X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta 2020;507:174–80.
26. Naess A, Nilssen SS, Mo R, Eide GE, Sjursen H. Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever. Infection 2017;45:299–307.